Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00144222
Brief Title: Combination of Telmisartan 40 mg Plus Hydrochlorothiazide (HCTZ) 12.5 mg vs. Telmisartan 40 mg Alone in Patients With Essential Hypertension Who Fail to Respond Adequately to Telmisartan Monotherapy

First Submitted : September 2, 2005
First Submitted that Met QC Criteria : September 2, 2005
First Posted : September 5, 2005 (Estimate)

Last Update Submitted that Met QC Criteria : November 4, 2013
Last Update Posted : November 5, 2013 (Estimate)